U.S. Specialized REITs Stock News

Global Partners came into this print with a solid recent run and a stock at about $50 that already reflected some optimism. The 3.4% pop after earnings indicates that investors liked what they saw. The headline is simple: profitability in this fuel and convenience network looks much stronger, with Q2 net income of $71.0 million and adjusted earnings before interest, tax, depreciation and amortization of $148.2 million. For income-focused holders, the raised quarterly cash distribution to...

In the past week, Constellation Energy reported second-quarter 2026 results showing sales of US$7,504 million and net income of US$513 million, while also affirming a quarterly dividend of US$0.4265 per share and announcing board leadership changes including CEO Joseph Dominguez becoming Chair. Despite quarterly earnings per share falling year on year, the company raised its full-year operating earnings guidance on the back of long-dated nuclear contracts with large, investment-grade...

Warner Bros. Discovery reported past second-quarter 2026 results showing revenue slipping to US$8,717 million from US$9,812 million a year earlier, while quarterly net income fell to US$149 million and the first half swung to a US$2.77 billion net loss from a US$1.13 billion profit. Behind these weaker headline numbers, the company’s streaming arm surpassed US$3 billion in quarterly revenue, helped by the Max–Disney+–Hulu bundle that reduced churn, even as management continued to back the...

Calumet stock dropped 5.7% to close at US$39.48 after its latest earnings, even though the quarter featured one clear headline. The company produced US$175m of adjusted earnings before interest, tax, depreciation and amortization, and generated more than US$90m of cash from operations, while continuing to pay down debt. In the short term, traders are reacting to a red price screen. Over a multi year horizon, the real story is the balance sheet repair. Management is retiring higher cost...

Elanco Animal Health (ELAN) is back in focus after receiving an Emergency Use Authorization from the U.S. Food and Drug Administration for CLiK Extra wound spray to help prevent New World screwworm infestations in livestock and captive wildlife. See our latest analysis for Elanco Animal Health. The Emergency Use Authorization comes shortly after Elanco Animal Health reported second quarter revenue of US$1,368 million and higher net income, alongside raised 2026 guidance. However, the stock’s...

Restaurant Brands International recently reported its second-quarter 2026 results, with revenue rising to US$2,520 million and net income increasing to US$507 million, alongside a US$0.65 third-quarter dividend declaration and completion of a 2,747,994-share buyback tranche costing US$205.86 million. The sharp year-on-year jump in earnings per share from continuing operations, with diluted EPS moving to US$1.45, highlights how current initiatives are translating into stronger...

Array Digital Infrastructure came into this earnings release with a bruised share price and a value label. The stock has fallen about 33% over the past three months, yet still trades on a trailing P/E of 4.6x compared with much richer wireless tower peers. Then Q2 landed with a jolt. Basic earnings per share jumped to US$3.86 and net income from ongoing operations reached US$333.77 million. The market barely flinched, with the stock slipping 1.1% to US$35.24 after the report. That muted move...

United Community Banks (NYSE:UCB) appointed Carl S. Carande to its Board of Directors and Risk Committee. Carande is a former KPMG International Head of Global Advisory with roughly four decades of financial services and consulting experience. The appointment adds expertise in global risk, technology, and organizational strategy to United Community Banks' governance structure. For more context on where United Community Banks fits within the sector, consider exploring other bank and...

Star Bulk Carriers has delivered a 151.7% total return over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to the stock trading at a discount of around 40.1% to fair value. That mix of strong long term performance and ongoing valuation gap is drawing fresh attention after the latest earnings update and fleet expansion plans. Over five years the stock is up 151.7%, which means long term holders have already seen...

Oscar Health, Inc. reported a sharp turnaround in past second-quarter 2026 results, moving from a net loss to net income of US$361.81 million and lifting basic earnings per share from continuing operations to US$1.20 from a loss per share of US$0.89 a year earlier. Over the first half of 2026, Oscar Health generated US$1.04 billions in net income and significantly higher earnings per share, while also highlighting technology and AI initiatives that are helping improve efficiency and...

Fluor stock just put in a 16.9% one day jump, and that kind of move demands a sanity check. The headline is not a one off accounting quirk. Investors are reacting to a construction and engineering giant that delivered Q2 revenue of US$4.3b and adjusted earnings per share of US$0.91, while locking in US$6.1b of new awards and pushing backlog toward US$27b. The real story is whether this surge reflects a clean reset of sentiment on Fluor’s order book and earnings power, or if buyers are...

Why CVS Health’s latest earnings and guidance matter for stock watchers CVS Health (CVS) has drawn fresh attention after strong second quarter 2026 results, a higher full year earnings outlook, and a broad revamp of its GLP 1 focused weight management program. For the second quarter ended June 30, 2026, CVS Health reported sales of US$35.1b compared with US$34.2b a year earlier. Revenue for the period was US$106.1b compared with US$98.9b in the prior year quarter. Quarterly net income was...

After a sharp pullback in recent weeks, Sezzle still sits on a strong year to date gain, and current valuation checks suggest the stock no longer looks obviously cheap or clearly expensive at around this level. Year to date, Sezzle has returned 81.2%, which means recent buyers are now weighing how much of the good news is already reflected in the price. The business is expanding its product suite and funding capacity, which can support growth expectations. At the same time, the recent share...

BlackLine's share price has fallen sharply over the past five years, yet the valuation checks now suggest the stock is closer to fairly priced than a clear bargain or an obvious excess. BlackLine has declined 73.6% over the past five years, which puts a lot of past optimism into question and makes the current price more about what happens next than what has happened so far. The recent launch of Verity Prepare AI can support the case for better long term economics if adoption is strong, while...

Why Gulfport Energy’s latest quarter is drawing attention Gulfport Energy (GPOR) has moved into focus after second quarter results showed lower quarterly revenue, net income, and production, alongside fresh full year production guidance and the upcoming resignation of its Chief Financial Officer. For you as an investor, this cluster of updates raises several questions. The mix of softer quarterly metrics, leadership change at the finance helm, and new production targets can influence how you...

Trip.com Group stock has delivered an 86.1% gain over the past 5 years, yet the broader valuation checks still suggest the shares lean cheap. Recent share price weakness in 2026 leaves investors weighing that longer term return against a high value score and mixed shorter term performance. Over 5 years, Trip.com Group is up 86.1%, which points to meaningful value creation for longer term holders despite recent setbacks. The 2025 Sustainability Report and the new US$100 million Tourism...

Douglas Elliman slipped 0.6% to US$1.78 after its second quarter report, a muted move for a stock tied to luxury housing sentiment. The headline is not the price; it is the sharp improvement in the income statement. Revenue was US$283.4m and the quarterly loss narrowed to US$2.7m. For a brokerage that only recently turned profitable on a trailing basis, that combination turns today’s dip into a sentiment check rather than a clear verdict. The rest of the report shows how fragile or durable...

In the second quarter of 2026, Upbound Group, Inc. reported sales of US$903.7 million, revenue of US$1.16 billion, and net income of US$21.58 million, with basic earnings per share from continuing operations of US$0.37, all modestly higher than a year earlier. The company also narrowed its full-year 2026 consolidated revenue outlook to US$4.70–US$4.85 billion and issued third-quarter revenue guidance of US$1.05–US$1.15 billion, giving investors a clearer view of expected scale and earnings...

A surprise loss of 23,000 US jobs in July and softer wage growth has put resilience back in the spotlight. Healthcare giants in areas such as pharmaceuticals and medical equipment are often watched closely when the broader economy looks less certain, because demand for many treatments can remain steady. This article reveals 3 large healthcare stocks from our screener that appear well placed against this backdrop. The three stocks highlighted below are just a sample from this theme, with the...

Karman Holdings (KRMN) drew investor attention on 6 August 2026 after reporting second quarter earnings, raising full year revenue guidance to between US$730 million and US$745 million, and amending its credit facility. See our latest analysis for Karman Holdings. The strong second quarter report, raised guidance and lower financing costs have been met with a sharp swing in sentiment toward Karman Holdings. The 1 day share price return is 5.6% and the 7 day share price return is 20.9%...

Regulatory milestone puts focus on GRAIL stock GRAIL (GRAL) is in the spotlight after the FDA scheduled a September 23, 2026 advisory committee meeting to review the Premarket Approval application for its Galleri multi cancer early detection blood test. See our latest analysis for GRAIL. The FDA panel date has come alongside GRAIL’s recent Q2 update and a sharp 1 day share price return of 9.59%, even though the year to date share price return is down 21.82%. Over the past year, the total...

Newsmax stock focus after recent trading performance Newsmax (NMAX) has drawn attention after recent trading, with the stock closing at $8.97 on 6 August 2026. Short term moves included a 4.79% gain over the past day and 16.34% over the past week. See our latest analysis for Newsmax. For context, Newsmax’s recent momentum has been strong, with a 90 day share price return of 40.60% and a year to date share price return of 13.83%, even though the 1 year total shareholder return declined...

Biglari Holdings stock barely flinched after earnings, easing just 0.3%, yet the headline result was anything but quiet. A swing to basic earnings per share of US$158.17 for the quarter, alongside net income of US$39.93 million, marks a sharp break from the recent run of losses. The market still treats Biglari as an unprofitable story with stretched valuation, which sets up a sentiment clash between the trailing weakness and a powerful single quarter of profitability. Is Biglari Holdings now...

Essent Group stock jumped 4.9% to US$68.72 after earnings, a strong move for a mortgage insurer that investors usually treat as a slow compounder rather than a trading vehicle. The headline is simple: profitability held up and the balance sheet stayed thick with capital even as net profit margin over the past year sat at 51.5%, below the earlier 56.4% level investors had grown used to. Short term traders see a pop. Long term holders see a company earning US$2.09 per share this quarter while...